Exploring the impact of Helicobacter pylori and potential gut microbiome modulation

Helicobacter pylori is a highly prevalent bacteria that can harm humans due to its major involvement in developing gastrointestinal diseases, particularly gastric cancer. Therefore, eradicating H. one of the most important strategies for preventing Antibiotic treatment has always been gold standard infection. However, decreasing efficacy antibiotic therapy rising resistance and high incidence dysbiosis-related adverse effects resulted eradication failure. To enhance effectiveness therapy, modulate gut microbiome were proposed play positive role. Generally, integration probiotics or symbiotic into was shown rate reduce effects. This review aims discuss role effect carcinogenesis modulation